Artículos de revistas sobre el tema "Neuroendocrine signalling"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Neuroendocrine signalling".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Rogoza, Olesja, Kaspars Megnis, Marija Kudrjavceva, Aija Gerina-Berzina y Vita Rovite. "Role of Somatostatin Signalling in Neuroendocrine Tumours". International Journal of Molecular Sciences 23, n.º 3 (27 de enero de 2022): 1447. http://dx.doi.org/10.3390/ijms23031447.
Texto completoWithers, D. J. "Insulin receptor substrate proteins and neuroendocrine function". Biochemical Society Transactions 29, n.º 4 (1 de agosto de 2001): 525–29. http://dx.doi.org/10.1042/bst0290525.
Texto completoHarada, Kenichi, Yasunori Sato, Hiroko Ikeda, Maylee Hsu, Saya Igarashi y Yasuni Nakanuma. "Notch1-Hes1 signalling axis in the tumourigenesis of biliary neuroendocrine tumours". Journal of Clinical Pathology 66, n.º 5 (19 de febrero de 2013): 386–91. http://dx.doi.org/10.1136/jclinpath-2012-201273.
Texto completoIgaz, Péter. "Genetics of neuroendocrine tumours, hereditary tumour syndromes". Orvosi Hetilap 154, n.º 39 (septiembre de 2013): 1541–48. http://dx.doi.org/10.1556/oh.2013.29706.
Texto completoWebber, Jonathan y Ian A. Macdonald. "Signalling in body-weight homeostasis: neuroendocrine efferent signals". Proceedings of the Nutrition Society 59, n.º 3 (agosto de 2000): 397–404. http://dx.doi.org/10.1017/s0029665100000446.
Texto completoToescu, Emil C. y Govindan Dayanithi. "Neuroendocrine signalling: Natural variations on a Ca2+ theme". Cell Calcium 51, n.º 3-4 (marzo de 2012): 207–11. http://dx.doi.org/10.1016/j.ceca.2012.01.010.
Texto completoBeyer, Anna-Sophia Liselott, Daniel Kaemmerer, Jörg Sänger y Amelie Lupp. "Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study". International Journal of Molecular Sciences 23, n.º 21 (4 de noviembre de 2022): 13503. http://dx.doi.org/10.3390/ijms232113503.
Texto completoAschbacher, Kirstin, Maria Rodriguez-Fernandez, Herman van Wietmarschen, A. Janet Tomiyama, Shamini Jain, Elissa Epel, Francis J. Doyle y Jan van der Greef. "The hypothalamic–pituitary–adrenal–leptin axis and metabolic health: a systems approach to resilience, robustness and control". Interface Focus 4, n.º 5 (6 de octubre de 2014): 20140020. http://dx.doi.org/10.1098/rsfs.2014.0020.
Texto completoGérard, Corinne, Marie Lagarde, Flora Poizat, Sandrine Oziel-Taieb, Vincent Garcia, Catherine Roche, Patricia Niccoli, Anne Barlier y David Romano. "Kinome rewiring during acquired drug resistance in neuroendocrine neoplasms". Endocrine-Related Cancer 28, n.º 1 (enero de 2021): 39–51. http://dx.doi.org/10.1530/erc-19-0142.
Texto completoHrabovszky, E. y Z. Liposits. "Novel Aspects of Glutamatergic Signalling in the Neuroendocrine System". Journal of Neuroendocrinology 20, n.º 6 (junio de 2008): 743–51. http://dx.doi.org/10.1111/j.1365-2826.2008.01719.x.
Texto completoDavis, Tasha R., Mariah R. Pierce, Sadie X. Novak y James L. Hougland. "Ghrelin octanoylation by ghrelin O -acyltransferase: protein acylation impacting metabolic and neuroendocrine signalling". Open Biology 11, n.º 7 (julio de 2021): 210080. http://dx.doi.org/10.1098/rsob.210080.
Texto completoRico, Karen, Suzann Duan, Ritu L. Pandey, Yuliang Chen, Jayati T. Chakrabarti, Julie Starr, Yana Zavros et al. "Genome analysis identifies differences in the transcriptional targets of duodenal versus pancreatic neuroendocrine tumours". BMJ Open Gastroenterology 8, n.º 1 (noviembre de 2021): e000765. http://dx.doi.org/10.1136/bmjgast-2021-000765.
Texto completoMazzoccoli, Gianluigi, Lucia Anna Muscarella, Vito Michele Fazio, Ada Piepoli, Valerio Pazienza, Mariangela Pia Dagostino, Francesco Giuliani, Victoria O. Polyakova y Igor Kvetnoy. "Antiphase signalling in the neuroendocrine-immune system in healthy humans". Biomedicine & Pharmacotherapy 65, n.º 4 (julio de 2011): 275–79. http://dx.doi.org/10.1016/j.biopha.2011.02.002.
Texto completovon Arx, Claudia, Monica Capozzi, Elena López-Jiménez, Alessandro Ottaiano, Fabiana Tatangelo, Annabella Di Mauro, Guglielmo Nasti, Maria Lina Tornesello y Salvatore Tafuto. "Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms". Journal of Clinical Medicine 8, n.º 9 (22 de agosto de 2019): 1277. http://dx.doi.org/10.3390/jcm8091277.
Texto completoFurigo, Isadora C., Pryscila D. S. Teixeira, Paula G. F. Quaresma, Naira S. Mansano, Renata Frazão y Jose Donato. "STAT5 ablation in AgRP neurons increases female adiposity and blunts food restriction adaptations". Journal of Molecular Endocrinology 64, n.º 1 (enero de 2020): 13–27. http://dx.doi.org/10.1530/jme-19-0158.
Texto completoRobinson, Hugh P. C. y Leanne Li. "Autocrine, paracrine and necrotic NMDA receptor signalling in mouse pancreatic neuroendocrine tumour cells". Open Biology 7, n.º 12 (diciembre de 2017): 170221. http://dx.doi.org/10.1098/rsob.170221.
Texto completoChang, John P., Hamid R. Habibi, Yi Yu, Mina Moussavi, Caleb L. Grey y Joshua G. Pemberton. "Calcium and other signalling pathways in neuroendocrine regulation of somatotroph functions". Cell Calcium 51, n.º 3-4 (marzo de 2012): 240–52. http://dx.doi.org/10.1016/j.ceca.2011.11.001.
Texto completoAristizabal Prada, E. T. y C. J. Auernhammer. "Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets". Endocrine Connections 7, n.º 1 (enero de 2018): R1—R25. http://dx.doi.org/10.1530/ec-17-0286.
Texto completoHörsch, D., S. Tielke y J. Schrader. "Expression and activation of mTOR in neuroendocrine tumors. Effects of mTOR inhibition by RAD001 upon growth, cell cycle regulation and signalling in neuroendocrine cell lines". Journal of Clinical Oncology 25, n.º 18_suppl (20 de junio de 2007): 10570. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.10570.
Texto completoVitali, Eleonora, Valeria Cambiaghi, Alessandro Zerbi, Carlo Carnaghi, Piergiuseppe Colombo, Erika Peverelli, Anna Spada, Giovanna Mantovani y Andrea G. Lania. "Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours". Endocrine-Related Cancer 23, n.º 3 (5 de enero de 2016): 181–90. http://dx.doi.org/10.1530/erc-15-0358.
Texto completoMendez, Pablo, Iñigo Azcoitia y Luis Miguel Garcia-Segura. "Interdependence of oestrogen and insulin-like growth factor-I in the brain: potential for analysing neuroprotective mechanisms". Journal of Endocrinology 185, n.º 1 (abril de 2005): 11–17. http://dx.doi.org/10.1677/joe.1.06058.
Texto completoKolasińska-Ćwikła, Agnieszka. "The mTOR signalling pathways in the pathogenesis and treatment of neuroendocrine tumours". OncoReview 6, n.º 1 (31 de marzo de 2016): 37–42. http://dx.doi.org/10.5604/20828691.1198520.
Texto completoRauschenbach, I. Y., E. K. Karpova, N. V. Adonyeva, O. V. Andreenkova, N. V. Faddeeva, E. V. Burdina, A. A. Alekseev, P. N. Menshanov y N. E. Gruntenko. "Disruption of insulin signalling affects the neuroendocrine stress reaction in Drosophila females". Journal of Experimental Biology 217, n.º 20 (11 de septiembre de 2014): 3733–41. http://dx.doi.org/10.1242/jeb.106815.
Texto completoMeza-Herrera, CA, A. Gonzalez-Bulnes, RT Kridli, M. Mellado, CF Arechiga-Flores, H. Salinas y JM Luginbuhl. "Neuroendocrine, Metabolic and Genomic Cues Signalling the Onset of Puberty in Females". Reproduction in Domestic Animals 45, n.º 6 (8 de abril de 2009): e495-e502. http://dx.doi.org/10.1111/j.1439-0531.2009.01355.x.
Texto completoZanini, Sara, Francesco Giovinazzo, Daniele Alaimo, Ben Lawrence, Roswitha Pfragner, Claudio Bassi, Irvin Modlin y Mark Kidd. "GNA15 expression in small intestinal neuroendocrine neoplasia: Functional and signalling pathway analyses". Cellular Signalling 27, n.º 5 (mayo de 2015): 899–907. http://dx.doi.org/10.1016/j.cellsig.2015.02.001.
Texto completoTrumble, Benjamin C., Eric A. Smith, Kathleen A. O'Connor, Hillard S. Kaplan y Michael D. Gurven. "Successful hunting increases testosterone and cortisol in a subsistence population". Proceedings of the Royal Society B: Biological Sciences 281, n.º 1776 (7 de febrero de 2014): 20132876. http://dx.doi.org/10.1098/rspb.2013.2876.
Texto completoSimbolo, Michele, Giovanni Centonze, Luca Giudice, Federica Grillo, Patrick Maisonneuve, Anastasios Gkountakos, Chiara Ciaparrone et al. "Combined Large Cell Neuroendocrine Carcinomas of the Lung: Integrative Molecular Analysis Identifies Subtypes with Potential Therapeutic Implications". Cancers 14, n.º 19 (24 de septiembre de 2022): 4653. http://dx.doi.org/10.3390/cancers14194653.
Texto completoBeyer, Anna-Sophia Lieselott, Daniel Kaemmerer, Jörg Sänger, Katja Evert y Amelie Lupp. "Immunohistochemical Evaluation of Adaptor Protein FAM159B Expression in Normal and Neoplastic Human Tissues". International Journal of Molecular Sciences 22, n.º 22 (12 de noviembre de 2021): 12250. http://dx.doi.org/10.3390/ijms222212250.
Texto completoGrozinsky-Glasberg, Simona, Kate E. Lines, Shani Avniel-Polak, Chas Bountra y Rajesh V. Thakker. "Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs)". Endocrine-Related Cancer 27, n.º 9 (septiembre de 2020): R345—R355. http://dx.doi.org/10.1530/erc-20-0127.
Texto completoBlažević, Anela, Johannes Hofland, Leo J. Hofland, Richard A. Feelders y Wouter W. de Herder. "Small intestinal neuroendocrine tumours and fibrosis: an entangled conundrum". Endocrine-Related Cancer 25, n.º 3 (marzo de 2018): R115—R130. http://dx.doi.org/10.1530/erc-17-0380.
Texto completoBastos, Diogo Assed, Brenda Gumz y Frederico Costa. "Antitumour Effects of Somatostatin Analogues in the Treatment of Neuroendocrine Tumours". European Endocrinology 8, n.º 2 (2010): 94. http://dx.doi.org/10.17925/ee.2012.08.02.94.
Texto completoBastos, Diogo Assed, Brenda Gumz y Frederico Costa. "Antitumour Effects of Somatostatin Analogues in the Treatment of Neuroendocrine Tumours". European Oncology & Haematology 08, n.º 03 (2012): 156. http://dx.doi.org/10.17925/eoh.2012.08.3.156.
Texto completoSoengas, José Luis, José Miguel Cerdá-Reverter y María Jesús Delgado. "Central regulation of food intake in fish: an evolutionary perspective". Journal of Molecular Endocrinology 60, n.º 4 (mayo de 2018): R171—R199. http://dx.doi.org/10.1530/jme-17-0320.
Texto completoSpampatti, M. P., G. Vlotides, G. Spoettl, J. Maurer, B. Goeke, D. Conte y C. J. Auernhammer. "OC.09.2 ASPIRIN REDUCED CELL VIABILITY AND MTOR SIGNALLING IN NEUROENDOCRINE TUMOR CELL LINES". Digestive and Liver Disease 46 (marzo de 2014): S22. http://dx.doi.org/10.1016/s1590-8658(14)60059-1.
Texto completoAtkinson, T. J. "Central and peripheral neuroendocrine peptides and signalling in appetite regulation: considerations for obesity pharmacotherapy". Obesity Reviews 9, n.º 2 (marzo de 2008): 108–20. http://dx.doi.org/10.1111/j.1467-789x.2007.00412.x.
Texto completoClift, Ashley K. y Andrea Frilling. "Using genetics to inform the pharmacological targeting of neuroendocrine neoplasms". Endocrine-Related Cancer 27, n.º 9 (septiembre de 2020): R293—R305. http://dx.doi.org/10.1530/erc-20-0074.
Texto completoReubi, Jean Claude, Daniel Fourmy, Arnau Cordomi, Irina G. Tikhonova y Véronique Gigoux. "GIP receptor: Expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studies". Peptides 125 (marzo de 2020): 170229. http://dx.doi.org/10.1016/j.peptides.2019.170229.
Texto completoCella, Chiara Alessandra, Saverio Minucci, Francesca Spada, Salvatore Galdy, Mohamed Elgendy, Paola Simona Ravenda, Maria Giulia Zampino, Sabina Murgioni y Nicola Fazio. "Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: From bench to bedside". Cancer Treatment Reviews 41, n.º 9 (noviembre de 2015): 754–60. http://dx.doi.org/10.1016/j.ctrv.2015.06.008.
Texto completoStern, Javier E. "Nitric oxide and homeostatic control: an intercellular signalling molecule contributing to autonomic and neuroendocrine integration?" Progress in Biophysics and Molecular Biology 84, n.º 2-3 (febrero de 2004): 197–215. http://dx.doi.org/10.1016/j.pbiomolbio.2003.11.015.
Texto completoAvila, Matías A. "Long distance calling for liver regeneration: Identification of neuroendocrine signalling pathways activated after partial hepatectomy". Journal of Hepatology 54, n.º 3 (marzo de 2011): 403–5. http://dx.doi.org/10.1016/j.jhep.2010.08.009.
Texto completoJohnson, James D. y John P. Chang. "Function- and agonist-specific Ca2+signalling: The requirement for and mechanism of spatial and temporal complexity in Ca2+signals". Biochemistry and Cell Biology 78, n.º 3 (2 de abril de 2000): 217–40. http://dx.doi.org/10.1139/o00-012.
Texto completoTobiansky, Daniel J., George V. Kachkovski, Reilly T. Enos, Kim L. Schmidt, E. Angela Murphy y Kiran K. Soma. "Sucrose consumption alters steroid and dopamine signalling in the female rat brain". Journal of Endocrinology 245, n.º 2 (mayo de 2020): 231–46. http://dx.doi.org/10.1530/joe-19-0386.
Texto completoKenny, David A. y Kate Keogh. "409 Early life nutrition on the molecular control of sexual development in the bull". Journal of Animal Science 98, Supplement_4 (3 de noviembre de 2020): 187–88. http://dx.doi.org/10.1093/jas/skaa278.346.
Texto completoVillanueva, José, Yolanda Gimenez-Molina, Bazbek Davletov y Luis M. Gutiérrez. "Vesicle Fusion as a Target Process for the Action of Sphingosine and Its Derived Drugs". International Journal of Molecular Sciences 23, n.º 3 (19 de enero de 2022): 1086. http://dx.doi.org/10.3390/ijms23031086.
Texto completoKhan, Rao Saad Ali. "Endoscopic Sleeve Gastroplasty: Best Obesity Treatment". Pakistan Armed Forces Medical Journal 73, n.º 1 (22 de febrero de 2023): 1–2. http://dx.doi.org/10.51253/pafmj.v73i1.9966.
Texto completoSimpson, Sian J. S., Lorna I. F. Smith, Peter M. Jones y James E. Bowe. "UCN2: a new candidate influencing pancreatic β-cell adaptations in pregnancy". Journal of Endocrinology 245, n.º 2 (mayo de 2020): 247–57. http://dx.doi.org/10.1530/joe-19-0568.
Texto completoCapodanno, Y., F. O. Buishand, L. Y. Pang, J. Kirpensteijn, J. A. Mol y D. J. Argyle. "Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells". Endocrine-Related Cancer 25, n.º 2 (febrero de 2018): 131–44. http://dx.doi.org/10.1530/erc-17-0415.
Texto completoKidd, M., B. Svejda, R. Pfragner y I. M. Modlin. "Serotonin is a critical signalling molecule in the local and metastatic small intestinal neuroendocrine tumour microenvironment". Regulatory Peptides 164, n.º 1 (septiembre de 2010): 38. http://dx.doi.org/10.1016/j.regpep.2010.07.094.
Texto completoGarcia, Nicholas W., Timothy J. Greives, Devin A. Zysling, Susannah S. French, Emily M. Chester y Gregory E. Demas. "Exogenous insulin enhances humoural immune responses in short-day, but not long-day, Siberian hamsters ( Phodopus sungorus )". Proceedings of the Royal Society B: Biological Sciences 277, n.º 1691 (17 de marzo de 2010): 2211–18. http://dx.doi.org/10.1098/rspb.2009.2230.
Texto completoJiménez, Beatriz, Mei Ran Abellona U, Panagiotis Drymousis, Michael Kyriakides, Ashley K. Clift, Daniel S. K. Liu, Eleanor Rees et al. "Neuroendocrine Neoplasms: Identification of Novel Metabolic Circuits of Potential Diagnostic Utility". Cancers 13, n.º 3 (20 de enero de 2021): 374. http://dx.doi.org/10.3390/cancers13030374.
Texto completo